Sumaira Hanif

Sumaira Hanif

Auto-generated profile, based on publicly available information

Sumaira Hanif

Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences Henan University Kaifeng, Henan 475004, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Advanced Functional Materials
Verified
Journal Article
Open access
PMPir Muhammad
Pir Muhammad
AZAmir Zada
Amir Zada
JRJamshaid Rashid
Jamshaid Rashid
SHSumaira Hanif
Sumaira Hanif
YGYanan Gao
Yanan Gao
YWYanli Wang
Yanli Wang
Defect engineering is an emerging technology for tailoring nanomaterials' characteristics and catalytic performance in various applications. Recently, defect‐engineered nanoparticles have emerged as highly researched materials in catalytic applications because of their exceptional redox reaction capabilities and physicochemical and optical properties. The properties of nanomaterials can be readily adjusted by controlling the nature and concentration of defects within the nanoparticles, avoiding the need for intricate design strategies. This review investigates defect engineering in nanocatalysts, including the design, fabrication, and applications. Initially, the various categories and strategies of nanomaterial defects and their impacts on the nanocatalysts' electronic and surface properties, catalytic activity, selectivity, and stability are summarized. Then, the catalytic processes and their uses, including gas sensing, hydrogen (H2) evolutions, water splitting, reductions of carbon dioxide (CO2) and nitrogen to value‐aided products, pollutant degradation, and biomedical (oncotherapy, antibacterial and wound healing, and biomolecular sensing) applications are discussed. Finally, the limitations in defect engineering and the prospective paths for allowing the logical design and optimization of nanocatalytic materials for long‐term and efficient applications are also examined. This comprehensive review gives unique insights into the current state of defect engineering in nanocatalysts and inspires future research on exploiting shortcomings to improve and customize catalytic performance.

1 June 2020 in EBioMedicine
Verified
Journal Article
Open access
AXAngel Xie
Angel Xie
SHSumaira Hanif
Sumaira Hanif
JOJiang Ouyang
Jiang Ouyang
ZTZhongmin Tang
Zhongmin Tang
NKNa Kong
Na Kong
WTWei Tao
Wei Tao
The rapid development of nanotechnology results in the emergence of nanomedicines, but the effective delivery of drugs to tumor sites remains a great challenge. Prodrug-based cancer nanomedicines thus emerged due to their unique advantages, including high drug load efficiency, reduced side effects, efficient targeting, and real-time controllability. A distinctive characteristic of prodrug-based nanomedicines is that they need to be activated by a stimulus or multi-stimulus to produce an anti-tumor effect. A better understanding of various responsive approaches could allow researchers to perceive the mechanism of prodrug-based nanomedicines effectively and further optimize their design strategy. In this review, we highlight the stimuli-responsive pathway of prodrug-based nanomedicines and their anticancer applications. Furthermore, various types of prodrug-based nanomedicines, recent progress and prospects of stimuli-responsive prodrug-based nanomedicines and patient data in the clinical application are also summarized. Additionally, the current development and future challenges of prodrug-based nanomedicines are discussed. We expect that this review will be valuable for readers to gain a deeper understanding of the structure and development of prodrug-based cancer nanomedicines to design rational and effective drugs for clinical use.

24 April 2020 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
SASaud Asif Ahmed
Saud Asif Ahmed
QLQiao‐Bo Liao
Qiao‐Bo Liao
QSQi Shen
Qi Shen
Mirza Muhammad Faran Ashraf BaigMirza Muhammad Faran Ashraf Baig
Mirza Muhammad Faran Ashraf Baig
JZJuan Zhou
Juan Zhou
KWKang Wang
Kang Wang

3 August 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JYJiliang Yan
Jiliang Yan
SHSumaira Hanif
Sumaira Hanif
DZDongya Zhang
Dongya Zhang
MIMuhammad Ismail
Muhammad Ismail
XWXiao Wang
Xiao Wang
HWHaigang Wu
Haigang Wu

27 April 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
SASaud Asif Ahmed
Saud Asif Ahmed
QSQi Shen
Qi Shen
QLQiao-Bo Liao
Qiao-Bo Liao
JZJuan Zhou
Juan Zhou
SHSumaira Hanif
Sumaira Hanif
KWKang Wang
Kang Wang

20 December 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
PMPir Muhammad
Pir Muhammad
SHSumaira Hanif
Sumaira Hanif
JYJiliang Yan
Jiliang Yan
Fawad Ur RehmanFawad Ur Rehman
Fawad Ur Rehman
JWJiefei Wang
Jiefei Wang
BSBingyang Shi
Bingyang Shi
Iron detection is one of the critical markers to diagnose multiple blood-related disorders that correspond to various biological dysfunctions. The currently available anemia detection approach can be used only for pre-treated blood samples that interfere with the actual iron level in blood. Real-time detection approaches with higher sensitivity and specificity are certainly needed to cope with the commercial level clinical analyses. Herein, we presented a novel strategy to determine the blood iron that can be easily practiced at commercial levels. The blend of well-known iron-cyanide chemistry with nanotechnology is advantageous with ultrahigh sensitivity in whole blood analysis without any pre-treatments. This approach is a combined detection system of the conventional assay (UV-visible spectroscopy) with surface-enhanced Raman scattering (SERS). Organic cyanide modified silver nanoparticles (cAgNPs) can selectively respond to Fe3+ ions and Hb protein with a detection limit of 10 fM and 0.46 μg mL−1, respectively, without being affected by matrix interfering species in the complex biological fluid. We confirmed the clinical potential of our new cAgNPs by assessing iron-status in multiple anemia patients and normal controls. Our SERS-based iron quantitation approach is highly affordable for bulk-samples, cheap, quick, flexible, and useful for real-time clinical assays. Such a method for metal-chelation has extendable features of therapeutics molecular tracking within more complex living systems at cellular levels.